Taro Bannai

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Sustained Remission After Treatment with Rituximab in CIDP Without Nodal/Paranodal Antibodies.

Sustained Remission After Treatment with Rituximab in CIDP Without Nodal/Paranodal Antibodies.

Journal: Internal medicine (Tokyo, Japan)

Published: April 01, 2026

Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.

Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 27, 2026

Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study.

Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study.

Journal: The journal of prevention of Alzheimer's disease

Published: January 20, 2026

Sporadic Late-onset Nemaline Myopathy Presenting with Dropped Head Syndrome and Complicated with Sjögren's Syndrome.

Sporadic Late-onset Nemaline Myopathy Presenting with Dropped Head Syndrome and Complicated with Sjögren's Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: January 14, 2026

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab.

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab.

Journal: The journal of prevention of Alzheimer's disease

Published: January 11, 2026

Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series.

Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series.

Journal: Journal of clinical medicine

Published: December 19, 2025

EBV-negative, CNS-restricted iatrogenic lymphoproliferative disorder during long-term infliximab monotherapy: interval enlargement despite cessation and steroid responsiveness.

EBV-negative, CNS-restricted iatrogenic lymphoproliferative disorder during long-term infliximab monotherapy: interval enlargement despite cessation and steroid responsiveness.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: October 06, 2025

Reversible Parkinsonism With Recovery of 123 I-Ioflupane DAT‑SPECT After Treating Rheumatoid Meningitis.

Reversible Parkinsonism With Recovery of 123 I-Ioflupane DAT‑SPECT After Treating Rheumatoid Meningitis.

Journal: Clinical nuclear medicine

Published: September 17, 2025

Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies.

Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies.

Journal: Rheumatology (Oxford, England)

Published: December 10, 2024

Authors' Response.

Authors' Response.

Journal: Internal medicine (Tokyo, Japan)

Published: March 03, 2024

Asymptomatic Acute Cerebral Infarction in a Patient with Hemoglobin Köln.

Asymptomatic Acute Cerebral Infarction in a Patient with Hemoglobin Köln.

Journal: Internal medicine (Tokyo, Japan)

Published: November 19, 2023

Neuroleptic Malignant Syndrome After Lithium Withdrawal.

Neuroleptic Malignant Syndrome After Lithium Withdrawal.

Journal: Journal of clinical psychopharmacology

Published: September 08, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026